An adjuvanted pandemic influenza H1N1 vaccine provides early and long term protection in health care workers.
Madhun
Abdullah S
AS
Influenza Centre, The Gade Institute, University of Bergen, N-5021 Bergen, Norway.
Akselsen
Per Espen
PE
Sjursen
Haakon
H
Pedersen
Gabriel
G
Svindland
Signe
S
Nøstbakken
Jane Kristin
JK
Nilsen
Mona
M
Mohn
Kristin
K
Jul-Larsen
Asne
A
Smith
Ingrid
I
Major
Diane
D
Wood
John
J
Cox
Rebecca J
RJ
D000328:Adult; D000368:Aged; D000914:Antibodies, Viral / Q000097:blood; D004338:Drug Combinations; D005260:Female; D006282:Health Personnel; D006385:Hemagglutination Inhibition Tests; D006801:Humans; D053118:Influenza A Virus, H1N1 Subtype / Q000276:immunology*; D007252:Influenza Vaccines / Q000008:administration & dosage / Q000009:adverse effects / Q000276:immunology*; D007251:Influenza, Human / Q000276:immunology / Q000517:prevention & control* / Q000821:virology; D008297:Male; D008875:Middle Aged; D011136:Polysorbates / Q000008:administration & dosage / Q000009:adverse effects; D013185:Squalene / Q000008:administration & dosage / Q000009:adverse effects; D013997:Time Factors; D022223:Vaccines, Subunit / Q000008:administration & dosage / Q000009:adverse effects / Q000276:immunology; D024502:alpha-Tocopherol / Q000008:administration & dosage / Q000009:adverse effects
D000914:Antibodies, Viral; D004338:Drug Combinations; D007252:Influenza Vaccines; D011136:Polysorbates; D022223:Vaccines, Subunit; D013185:Squalene; C550253:AS03 adjuvant; D024502:alpha-Tocopherol